The objective of this study was to examine the role of oxygen radicals, pro
tein kinase C (PKC), and ATP-sensitive K+ (K-ATP) channels in mediating flu
mazenil-produced preconditioning. Chick cardiomyocyte death was quantified
using propidium iodide, and oxygen radical generation was assessed using 2'
, 7'-dichlorofluorescin oxidation. Preconditioning was initiated with 10 mi
n of ischemia followed by 10 min of reoxygenation. Alternatively, flumazeni
l was infused for 10 min and removed 10 min before ischemia. Flumazenil (10
muM) and preconditioning increased oxygen radicals [1,693 +/- 101 (n = 3)
and 1,567 +/- 98 (n = 3), respectively, vs. 345 +/- 53 (n = 3) in control]
and reduced cell death similarly [22 +/- 3% (n = 5) and 18 +/- 2% (n = 6),
respectively, vs. controls 49 +/- 5% (n = 8)]. Protection and increased oxy
gen radicals by flumazenil were abolished by pretreatment with the antioxid
ant thiol reductant 2-mercaptopropionyl glycine (800 muM; 52 +/- 10%, n = 6
). Specific PKC inhibitors Go-6976 (0.1 muM) and chelerythrine (2 muM), giv
en during ischemia and reoxygenation, blocked flumazenil-produced protectio
n (47 +/-, n = 6). The PKC activator phorbol 12-myristate 13-acetate (0.2 m
uM), given during ischemia and reoxygenation, reduced cell death similarly
to that with flumazenil [17 +/- (n =6) and 22 +/- (n = 5)]. Finally, 5-hydr
oxydecanoate (1 mM), a selective mitochondrial KATP channel antagonist give
n during ischemia and reoxygenation, abolished the protection of flumazenil
and phorbol 12-myristate 13-acetate. Thus flumazenil mimics preconditionin
g to reduce cell death in cardiomyocytes. Oxygen radicals activate mitochon
drial K-ATP channels via PKC during the process.